21 May 2013
Keywords: jazz, seizure, drug, gets, fda, orphan, status
Article | 14 January 2008
USA-based drugmaker Jazz Pharmaceuticals says its developmental seizure
treatment, JZP-8, has received Orphan Drug designation from the Food and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
20 May 2013
© 2013 thepharmaletter.com